Bryce Point Capital’s Medtronic MDT Stock Holding History

Bryce Point Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,134	Closed	-$490K	–	346
2024 Q4	$490K	Buy	+6,134	New	+$531K	0.14%	306

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bryce Point Capital's MDT Position: Q1 2025 in Review

Bryce Point Capital sold out of Medtronic (MDT) in Q1 2025, closing a stake of 6,134 shares — an estimated $490K sold.

Bryce Point Capital first reported a position in MDT in Q4 2024 and held it in 1 quarter. The position peaked at $490K in Q4 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

Bryce Point Capital reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 6,134 Medtronic shares in Q1 2025, an estimated $490K.
Bryce Point Capital first reported a position in Medtronic in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's Medtronic position peaked at $490K in Q4 2024.
2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.